EUVIMEDEUVIMED entdecken
Open Access

Clinical Outcomes of Fractional Carbon Dioxide Laser Treatment in Women With Vulvar Lichen Simplex Chronicus: A Retrospective Study With 12‐Month Follow‐Up

Nengxiu Wu iD, Siai Chen, Chaoqin Lin iD, Qi Wang iD

Lasers in Surgery and Medicine · 2026-09 · 58 (7) · 516-523

DOI: 10.1002/lsm.70148 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Lasers in Surgery and Medicine, online erschienen am 15.05.2026. Verfasst von Nengxiu Wu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzho…. Hauptthemen laut MEDLINE: Lasers, Gas, Neurodermatitis. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate the efficacy and safety of fractional carbon dioxide (CO 2 ) laser therapy in women with vulvar lichen simplex chronicus (VLSC).

Methods

This retrospective study included 88 women with VLSC who underwent three sessions of fractional CO 2 laser treatment between January 2022 and January 2024. Clinical outcomes were assessed using the Cattaneo clinical symptom and sign scoring system to calculate the therapeutic efficacy index. Vulvar pruritus and dyspareunia were evaluated using a visual analog scale (VAS), and patient‐reported global improvement was assessed with the Patient Global Impression of Change (PGI‐C) questionnaire. Follow‐up assessments were conducted at 1, 6, and 12 months after treatment.

Results

At 1, 6, and 12 months post‐treatment, significant reductions were observed in VAS scores for vulvar pruritus and dyspareunia, as well as in Cattaneo clinical symptom and sign scores (all p < 0.05). The overall response rates were 89.8% (79/88; 95% confidence interval [CI], 81.7%–94.5%), 93.2% (82/88; 95% CI, 85.9%–96.8%), and 88.6% (78/88; 95% CI, 80.3%–93.7%), respectively. According to the PGI‐C questionnaire, the proportions of patients reporting improvement or marked improvement were 72.7%, 78.4%, and 70.5% at the corresponding follow‐up time points. No significant differences in treatment outcomes were observed according to disease duration or menopausal status.

Conclusion

Fractional CO 2 laser therapy was associated with significant and sustained improvement in clinical symptoms and signs of VLSC, suggesting that it may represent a promising therapeutic option for selected women with VLSC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lasers, GasNeurodermatitisHumansFemaleRetrospective StudiesFollow-Up StudiesMiddle AgedTreatment OutcomeAdultAged

Stichwörter der Autor:innen

dyspareuniafractional carbon dioxide laserpatient‐reported outcomesvulvar lichen simplex chronicusvulvar pruritus

Autor:innen und Institutionen

  • Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, Fujian Province, China.

ORCID-Profile: Nengxiu Wu, Chaoqin Lin, Qi Wang

Zitieren

APA

Wu, N., Chen, S., Lin, C., & Wang, Q. (2026). Clinical Outcomes of Fractional Carbon Dioxide Laser Treatment in Women With Vulvar Lichen Simplex Chronicus: A Retrospective Study With 12‐Month Follow‐Up. Lasers in Surgery and Medicine, 58(7), 516-523. https://doi.org/10.1002/lsm.70148

Vancouver

Wu N, Chen S, Lin C, Wang Q. Clinical Outcomes of Fractional Carbon Dioxide Laser Treatment in Women With Vulvar Lichen Simplex Chronicus: A Retrospective Study With 12‐Month Follow‐Up. Lasers in Surgery and Medicine. 2026;58(7):516-523. doi:10.1002/lsm.70148

BibTeX
@article{Wu2026,
  author = {Wu, Nengxiu and Chen, Siai and Lin, Chaoqin and Wang, Qi},
  title = {Clinical Outcomes of Fractional Carbon Dioxide Laser Treatment in Women With Vulvar Lichen Simplex Chronicus: A Retrospective Study With 12‐Month Follow‐Up},
  journal = {Lasers in Surgery and Medicine},
  year = {2026},
  volume = {58},
  number = {7},
  pages = {516--523},
  doi = {10.1002/lsm.70148}
}
Kostenlos starten →